Matthew J. Lisenby, O.D.
Optometrist · Montrose, CO
Matthew J. Lisenby, O.D. is an optometrist with a practice address in Montrose, Colorado, and NPI 1043516784, issued on Jan 27, 2011. Check the license (Colorado 2792, as entered in NPPES) with the Colorado board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Matthew J. Lisenby
- Credential
- O.D.
- Primary taxonomy
- Optometrist 152W00000X
- License number
- 2792 CO
Self-reported in NPPES; status is on the state search - Practice location
- 2770 Woodgate RD, Montrose, CO 81401
- Phone
- (970) 249-2330
- Enumerated
- Jan 27, 2011
- Record last updated
- Dec 29, 2020 (not updated in 6 years: call before relying on the address or phone)
- Fax
- (970) 249-6131
- Medicaid ID
- 19674244 CO
- Medicare enrollment
- Enrolled (PECOS I20120725001109); accepts Medicare assignment
- Medical or professional school
- Pacific University - College Of Optometry, 2010
- Entity
- Type 1 · individual
8 nearest optometrist records → All 1,273 in Colorado → Look up another NPI →
Also registered at 2770 Woodgate RD
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kelly Cyr, O.D.Optometrist1053542530
- Abraham Wilson, O.D.Optometrist1366762288
Verify Matthew J. Lisenby in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Colorado board licenses this profession
Search for license 2792Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
74% more Medicare Part D claims than the average optometrist in 2024
482 Medicare Part D claims for 110 beneficiaries, against an average of 277 among the 33,128 providers of this specialty who prescribed in Part D. Brand-name drugs were 24% of claims.
Most prescribed
- Latanoprost282 claims
- Timolol Maleate38 claims
- Travoprost15 claims
- Tobramycin-Dexamethasone13 claims
- Fluorometholone12 claims
- Brimonidine Tartrate11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 0 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Bills Medicare through one group practice
- Vista Vision Family Eye Care LLCMontrose, CO
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Matthew J. Lisenby among 1,273 optometrist records in Colorado
Matthew J. Lisenby, O.D. is one of 1,273 optometrist records with a practice address in Colorado. 72% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2011, is newer than 62% of them.
- NPI issued2011 · 62% of these records are older, 35% newer
- In a Medicare fileYes · 72% of these records are
- In the CMS Doctors and Clinicians fileYes · 59% of these records are
- Graduated2010 · median 2009 among the 750 with a school on file
- Record last updated2020 · 63% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 152W00000X and a Colorado practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Optometrist providers in Colorado
There are 1,273 optometrist records in Colorado.
All 1,273 in Colorado → Every provider in Montrose → Optometrist nationwide →
The 8 optometrist records with the nearest ZIP codes
- Christopher Buchanan, O.D.Montrose, CO 814011326096736
- Wesley Cooper, ODMontrose, CO 814011841290319
- Kelly Cyr, O.D.Montrose, CO 814011053542530
- Joanna Daly, ODMontrose, CO 814011811247083
- Larry Kinnick, O.D.Montrose, CO 814011801874334
- Abraham Wilson, O.D.Montrose, CO 814011366762288
- Charles Young, O.D.Montrose, CO 814011134283641
- Cory Christensen, ODDelta, CO 814161255853974
Common questions
What is Matthew J. Lisenby, O.D.'s NPI number?
Matthew J. Lisenby, O.D.'s National Provider Identifier (NPI) is 1043516784, issued on Jan 27, 2011. An NPI identifies a provider in billing; it is not a license.
Where is Matthew J. Lisenby, O.D. located?
The NPPES record lists a practice address at 2770 Woodgate RD, Montrose, CO, 81401. Phone: (970) 249-2330. Providers update this record themselves, so call before visiting.
How can I verify Matthew J. Lisenby, O.D.'s license?
NPPES lists Colorado license number 2792, as entered by the provider. Search the Colorado board that licenses this profession; the NPPES record confirms identity only.
How much does Matthew J. Lisenby, O.D. prescribe under Medicare Part D?
In 2024, Matthew J. Lisenby, O.D. had 482 Medicare Part D claims for 110 beneficiaries; the average among optometrist prescribers was 277. Part D covers Medicare prescriptions only.
What is Matthew J. Lisenby, O.D.'s MIPS final score?
The 2023 MIPS final score is 0 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.